Discover what clinical trials are, why they're vital for new treatments, and how you can participate in life-changing medical ...

Akebia Therapeutics, Inc. (NASDAQ:AKBA) is one of the 12 Small Cap Stocks with High Upside Potential. On June 4, the company ...

The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to ...

India has reached the 50 per cent enrolment mark in its first phase III clinical trial for the indigenous tetravalent dengue ...

Phase 1b studies for ABI-1179 and ABI-5366 running concurrently ... Assembly Bio’s ability to maintain financial resources necessary to continue its research activities, clinical studies and other ...

Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class client experience, Novotech sets the global standard in contract research for biotechs and small- ...

Laekna (2105.HK) announced today that the results of: i) the phase I SAD study of LAE102 (an ActRIIA-selective antibody) for ...

Recently, alternative endpoints, including progression-free survival (PFS), have emerged as popular readouts for many phase 3 clinical trials. PFS indicates the time from diagnosis (or treatment ...

Though caution is required when the data haven't been published, it could be a landmark in the drug's journey toward FDA ...

Akebia Therapeutics, Inc. announced the publication of pre-specified analyses from its global phase 3 clinical trials of vadadustat for treating anemia in chronic kidney disease (CKD) in the ...